Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mala Rao

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
Journal of Fluorescence|December 6, 2012
Mechanistic insights into the inhibition of endo-β 1,4 xyloglucan hydrolase by a classical aspartic protease inhibitorVishnu Menon, Mala Rao
Applied Biochemistry and Biotechnology|August 22, 2014
Interactions of a low molecular weight inhibitor from Streptomyces sp. MBR04 with human cathepsin D: implications in mechanism of inactivationVishnu Menon, Mala Rao
Global Health Action|February 25, 2014
The missing link--the role of primary care in global healthMala Rao, Eva Pilot
Biochemical and Biophysical Research Communications|February 22, 2005
Purification and properties of a low molecular weight 1,4-beta-d-glucan glucohydrolase having one active site for carboxymethyl cellulose and xylan from an alkalothermophilic Thermomonospora spSharmili Jagtap, Mala Rao
Microbiology (Reading, England)|April 12, 2012
A low-molecular-mass aspartic protease inhibitor from a novel Penicillium sp.: implications in combating fungal infectionsVishnu Menon, Mala Rao
Biochimica Et Biophysica Acta|September 20, 2006
Biochemical characterization of a low molecular weight aspartic protease inhibitor from thermo-tolerant Bacillus licheniformis: kinetic interactions with PepsinAjit Kumar, Mala Rao
BMJ (Clinical Research Ed.)|February 6, 2013
Aviation and public healthJangu Banatvala, Mala Rao
BMJ (Clinical Research Ed.)|October 9, 2020
Towards a carbon neutral NHSNeil Jennings, Mala Rao
BMJ (Clinical Research Ed.)|February 19, 2025
Has racism in medicine improved since 2020?Mala Rao, Victor Adebowale
The Journal of Biological Chemistry|August 20, 2004
Inhibition of 1,4-beta-D-xylan xylanohydrolase by the specific aspartic protease inhibitor pepstatin: probing the two-step inhibition mechanismVinod Vathipadiekal, Mala Rao
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
Journal of Fluorescence|December 6, 2012
Mechanistic insights into the inhibition of endo-β 1,4 xyloglucan hydrolase by a classical aspartic protease inhibitorVishnu Menon, Mala Rao
Applied Biochemistry and Biotechnology|August 22, 2014
Interactions of a low molecular weight inhibitor from Streptomyces sp. MBR04 with human cathepsin D: implications in mechanism of inactivationVishnu Menon, Mala Rao
Global Health Action|February 25, 2014
The missing link--the role of primary care in global healthMala Rao, Eva Pilot
Biochemical and Biophysical Research Communications|February 22, 2005
Purification and properties of a low molecular weight 1,4-beta-d-glucan glucohydrolase having one active site for carboxymethyl cellulose and xylan from an alkalothermophilic Thermomonospora spSharmili Jagtap, Mala Rao
Microbiology (Reading, England)|April 12, 2012
A low-molecular-mass aspartic protease inhibitor from a novel Penicillium sp.: implications in combating fungal infectionsVishnu Menon, Mala Rao
Biochimica Et Biophysica Acta|September 20, 2006
Biochemical characterization of a low molecular weight aspartic protease inhibitor from thermo-tolerant Bacillus licheniformis: kinetic interactions with PepsinAjit Kumar, Mala Rao
BMJ (Clinical Research Ed.)|February 6, 2013
Aviation and public healthJangu Banatvala, Mala Rao
BMJ (Clinical Research Ed.)|October 9, 2020
Towards a carbon neutral NHSNeil Jennings, Mala Rao
BMJ (Clinical Research Ed.)|February 19, 2025
Has racism in medicine improved since 2020?Mala Rao, Victor Adebowale
The Journal of Biological Chemistry|August 20, 2004
Inhibition of 1,4-beta-D-xylan xylanohydrolase by the specific aspartic protease inhibitor pepstatin: probing the two-step inhibition mechanismVinod Vathipadiekal, Mala Rao
Pageof 11